Too Long; Didn't Read
Berlin-based, non-profit think tank dGen has just released a new report, “AI, Privacy, and Genomics: The Next Era of Drug Design” The report looks at the issue of privacy and access to genetic data for companies using AI to speed up and improve drug design. The average drug today takes 10-12 years and costs $2 billion. AI is only just entering drug R&D where it is being used to test and improve candidate drugs before they can be fully accredited by regulators.
Share Your Thoughts